James Laufenberg
Lenexa, KS (USA)
Role(s):
ImmunoGenetix
Find More Startups
Startup
Location:
Lenexa
Industry:
Bio-Technology
Year Founded:
2003
Number Employees:
INVALID
Description:
ImmunoGenetix Therapeutics, Inc. is an early stage biotechnology company developing advanced DNA-based therapies for the treatment of viral infections, with a focus on HIV. Our proprietary lead candidate, GenePro™, has published efficacy studies in non-human primates with promising results. The market for HIV / AIDS is large and growing. The US HIV therapeutic drug market alone is doubling to sales of over $13 billion by 2011